Correct controlled ovarian stimulation is of paramount importance in assisted reproductive
technologies. Therefore, analysis of the ovarian reserve of the patient is mandatory to tailor …

Gonadotropin-releasing hormone (GnRH) antagonists, which became commercially
available from 1999, have been used for the prevention of premature luteinizing hormone …

BACKGROUND Serum concentrations of anti-Müllerian hormone (AMH) correlate with
oocyte yield in assisted reproduction treatment (ART) cycles, however, performance of AMH …

BACKGROUND. This is the first published report of a prospective, randomized, controlled
trial comparing a fixed, multi-dose GnRH antagonist protocol with a long GnRH agonist …

OBJECTIVE: To compare the efficacy of a microdose GnRH agonist flare (ML) with a GnRH
antagonist/letrozole (AL) protocol before IVF-ET in poor responders. DESIGN: Prospective …

OBJECTIVE: To compare the effects of oral contraceptive (OC) pill pretreatment in
recombinant FSH/GnRH-antagonist versus recombinant FSH/GnRH-agonist stimulation in in …

The aim of this prospective study was to evaluate the efficacy of gonadotrophin-releasing
hormone antagonist (GnRH) in comparison with the standard long protocol in poor …

OBJECTIVE: To compare the efficacy of microdose GnRH agonist (GnRH-a) flare-up and
multiple dose GnRH antagonist protocols in patients who have a poor response to a long …

OBJECTIVE: To compare the efficacy of the microdose flare-up and multiple-dose antagonist
protocols for poor-responder patients in intracytoplasmic sperm injection–ET cycles …

OBJECTIVE: To compare embryo and oocyte data between a standard protocol and a luteal
phase estradiol protocol. DESIGN: Retrospective paired cohort analysis. SETTING: Private …